Latest Pharmacy News

Page 8 of 17
MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.
Ada Torres
Ada Torres
22 Oct 2025
MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.
Ada Torres
Ada Torres
22 Oct 2025
Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.
Ada Torres
Ada Torres
20 Oct 2025
Biome Australia Limited has reported a record quarterly revenue of $5.94 million for Q1 FY26, marking a 40% increase year-over-year and its seventh consecutive quarter of positive EBITDA. The company’s strong cash flow and sustained margins underscore its growth momentum.
Ada Torres
Ada Torres
17 Oct 2025
Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.
Ada Torres
Ada Torres
15 Oct 2025
Immuron Limited reports a robust 34% year-on-year sales increase for Q1 FY26, driven by strong growth in Australia and the USA, while Canadian sales dip seasonally. The company’s marketing efforts and expanding retail presence underpin this momentum.
Ada Torres
Ada Torres
13 Oct 2025
Biome Australia Limited has reported a record-breaking $5.94 million in sales revenue for Q1 FY26, surpassing forecasts and accelerating toward its ambitious Vision 27 revenue goals.
Ada Torres
Ada Torres
1 Oct 2025
ParagonCare has released its audited FY25 financial results, confirming steady profit while revealing a significant reclassification of debt and ongoing challenges with a major retail pharmacy receivable.
Ada Torres
Ada Torres
30 Sept 2025
Washington H. Soul Pattinson and Brickworks have finalized their share schemes, exchanging existing shares for Topco shares and marking Brickworks’ imminent ASX delisting.
Victor Sage
Victor Sage
23 Sept 2025
EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.
Ada Torres
Ada Torres
22 Sept 2025
The Supreme Court of New South Wales has approved the merger scheme between Washington H. Soul Pattinson and Brickworks, paving the way for a new ASX-listed entity, Topco. Shareholders will soon exchange their Soul Patts shares for Topco shares as trading transitions next week.
Claire Turing
Claire Turing
12 Sept 2025
Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.
Ada Torres
Ada Torres
2 Sept 2025